New Medicare Rules May Increase Risk from Unregulated Compounded Drug Copies
Rep. Waxman asks HHS to revise the proposed Medicare rule that would allow the use of pharmacist-made copies of brand-name prescription drugs to ensure that seniors are not exposed to the serious health risks posed by these non-FDA approved drugs.